Is HDL good or bad?

HDL cholesterol is considered 'good' because it helps remove excess cholesterol from your bloodstream and protects against heart disease. However, extremely high HDL levels (above 80-100 mg/dL) may paradoxically increase cardiovascular risk in some cases.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

What Is HDL Cholesterol?

HDL stands for high-density lipoprotein, one of the five major groups of lipoproteins that transport cholesterol and triglycerides through your bloodstream. Unlike its counterpart LDL (low-density lipoprotein), which is often called 'bad' cholesterol, HDL has earned the nickname 'good' cholesterol for its protective role in cardiovascular health.

Think of HDL as your body's cleanup crew. These particles act like molecular vacuum cleaners, traveling through your bloodstream and collecting excess cholesterol from your arteries and tissues. They then transport this cholesterol back to your liver, where it can be broken down and removed from your body through bile.

The Structure and Function of HDL

HDL particles are the smallest and densest of all lipoproteins, composed of about 50% protein and 50% lipids. This high protein content gives them their density and unique properties. The main protein component, apolipoprotein A-I (ApoA-I), is crucial for HDL's ability to remove cholesterol from cells and protect against atherosclerosis.

HDL Cholesterol Levels and Cardiovascular Risk

HDL Level (mg/dL)CategoryCardiovascular RiskRecommended Action
Below 40 (men) / Below 50 (women)<40 (M) / <50 (F)LowHigh riskImmediate lifestyle changes, consider medication
40-5940-59 mg/dLBorderlineModerate riskLifestyle modifications recommended
60-8060-80 mg/dLOptimalLow riskMaintain healthy habits
Above 80-100>80-100 mg/dLHighPotentially increased riskEvaluate HDL function, check for underlying conditions

HDL levels should be interpreted alongside other cardiovascular risk factors and the complete lipid profile.

Beyond cholesterol transport, HDL particles have several other protective functions:

  • Anti-inflammatory properties that reduce arterial inflammation
  • Antioxidant effects that prevent LDL oxidation
  • Anti-thrombotic properties that reduce blood clot formation
  • Endothelial protection that maintains healthy blood vessel function

Why HDL Is Considered 'Good' Cholesterol

The primary reason HDL is labeled as 'good' cholesterol relates to its inverse relationship with cardiovascular disease risk. Numerous studies have shown that higher HDL levels are associated with lower rates of heart attacks, strokes, and other cardiovascular events.

The Reverse Cholesterol Transport Process

HDL's most important function is reverse cholesterol transport (RCT). This process involves several steps:

  1. HDL particles pick up excess cholesterol from peripheral tissues and arterial walls
  2. Cholesterol is esterified (chemically modified) within HDL particles
  3. HDL transports cholesterol to the liver
  4. The liver processes and eliminates cholesterol through bile production

This process is crucial because it prevents cholesterol accumulation in artery walls, which would otherwise lead to plaque formation and atherosclerosis. By maintaining this cholesterol highway back to the liver, HDL helps keep your arteries clear and reduces your risk of cardiovascular disease.

Cardiovascular Protection Beyond Cholesterol Transport

Research has revealed that HDL's protective effects extend beyond simple cholesterol removal. HDL particles contain numerous proteins and enzymes that provide additional cardiovascular benefits, including paraoxonase-1 (PON1), which protects LDL from oxidation, and sphingosine-1-phosphate (S1P), which promotes endothelial health and repair.

Optimal HDL Levels for Health

Understanding what constitutes healthy HDL levels is crucial for assessing your cardiovascular risk. The traditional guidelines have focused on minimum thresholds, but recent research suggests the relationship between HDL and health is more nuanced than previously thought.

For most adults, an HDL level of 60 mg/dL or higher is considered protective against heart disease. However, the optimal range appears to be between 50-80 mg/dL for men and 50-90 mg/dL for women. Women naturally tend to have higher HDL levels than men, partly due to the effects of estrogen.

Gender Differences in HDL Levels

The differences in HDL levels between men and women are significant and influenced by several factors:

  • Hormonal influences: Estrogen increases HDL production and decreases its clearance
  • Body composition: Women typically have higher body fat percentages, affecting lipid metabolism
  • Lifestyle factors: Differences in diet, exercise patterns, and alcohol consumption
  • Genetic variations: Sex-specific genetic factors influence HDL metabolism

These gender differences are important to consider when interpreting HDL results and setting health goals. Post-menopausal women often experience a decline in HDL levels, which partly explains the increased cardiovascular risk after menopause.

When High HDL Might Be Concerning

While HDL is generally protective, emerging research suggests that extremely high HDL levels might not always be beneficial. This paradox has led scientists to reconsider the simple 'more is better' approach to HDL cholesterol.

The U-Shaped Curve Phenomenon

Recent large-scale studies have identified a U-shaped relationship between HDL levels and mortality risk. While low HDL (below 40 mg/dL) is clearly associated with increased cardiovascular risk, very high HDL (above 80-100 mg/dL) may also be linked to adverse outcomes in some populations.

Several mechanisms might explain why extremely high HDL could be problematic:

  • Dysfunctional HDL: At very high levels, HDL particles may become less efficient at removing cholesterol
  • Genetic variants: Some genetic conditions causing high HDL are associated with increased cardiovascular risk
  • Underlying conditions: Extremely high HDL might indicate other metabolic abnormalities
  • Inflammatory states: In certain conditions, HDL can become pro-inflammatory rather than anti-inflammatory

Quality vs. Quantity

Modern research emphasizes that HDL function may be more important than HDL quantity. Factors that can impair HDL function include:

  • Chronic inflammation
  • Diabetes and metabolic syndrome
  • Smoking
  • Certain medications
  • Genetic variations affecting HDL metabolism

This understanding has led to the development of new tests that assess HDL functionality rather than just measuring HDL cholesterol levels. Understanding your complete lipid profile, including advanced markers like ApoA-I and ApoB, provides a more comprehensive view of your cardiovascular risk.

Factors That Influence HDL Levels

Your HDL levels are influenced by a complex interplay of genetic, lifestyle, and environmental factors. Understanding these influences can help you make informed decisions about managing your cholesterol levels.

Lifestyle Factors

Many modifiable lifestyle factors can significantly impact your HDL levels:

  • Physical activity: Regular aerobic exercise can increase HDL by 5-10%
  • Diet: Mediterranean-style diets rich in healthy fats boost HDL
  • Weight management: Losing excess weight can increase HDL by 1 mg/dL per 7 pounds lost
  • Smoking cessation: Quitting smoking can increase HDL by up to 10%
  • Moderate alcohol consumption: While controversial, moderate alcohol intake may raise HDL

Medical Conditions and Medications

Several medical conditions can lower HDL levels:

  • Type 2 diabetes and insulin resistance
  • Metabolic syndrome
  • Chronic kidney disease
  • Hypothyroidism
  • Chronic inflammatory conditions

Additionally, certain medications can affect HDL levels. Beta-blockers, anabolic steroids, and some progestins can lower HDL, while statins, fibrates, and niacin can raise it. Always discuss medication effects on cholesterol with your healthcare provider.

How to Naturally Increase HDL Levels

If your HDL levels are below optimal, several evidence-based strategies can help increase them naturally:

Dietary Approaches

  1. Increase omega-3 fatty acids: Consume fatty fish like salmon, mackerel, and sardines at least twice weekly
  2. Choose healthy fats: Replace saturated fats with monounsaturated fats from olive oil, avocados, and nuts
  3. Add soluble fiber: Include oats, beans, lentils, and fruits in your daily diet
  4. Consume antioxidant-rich foods: Berries, dark leafy greens, and colorful vegetables protect HDL function
  5. Consider plant sterols: Found in fortified foods and supplements, these can improve overall cholesterol profile

Exercise Recommendations

Exercise is one of the most effective ways to boost HDL levels. The American Heart Association recommends:

  • At least 150 minutes of moderate-intensity aerobic exercise per week
  • Or 75 minutes of vigorous-intensity aerobic exercise per week
  • Resistance training at least twice per week
  • High-intensity interval training (HIIT) for additional HDL benefits

Studies show that aerobic exercise can increase HDL by 5-10%, with the greatest benefits seen in those who start with lower HDL levels and higher body weights.

Testing and Monitoring Your HDL

Regular monitoring of your HDL levels is an important part of cardiovascular health management. HDL is typically measured as part of a standard lipid panel, which also includes total cholesterol, LDL cholesterol, and triglycerides.

When and How Often to Test

Testing frequency depends on your risk factors and current health status:

  • Healthy adults: Every 4-6 years starting at age 20
  • Those with risk factors: Annually or as recommended by your healthcare provider
  • People making lifestyle changes: Every 3-6 months to track progress
  • Those on cholesterol medications: As directed by your physician, typically every 3-6 months

For the most accurate results, fast for 9-12 hours before testing and avoid alcohol for 24 hours prior. Regular monitoring helps you track the effectiveness of lifestyle changes and medical interventions.

Advanced Lipid Testing

Beyond standard HDL measurements, advanced tests can provide more detailed information about your cardiovascular risk:

  • HDL particle number and size: Measures the quantity and quality of HDL particles
  • ApoA-I levels: The main protein component of HDL, directly related to HDL function
  • HDL functionality tests: Assess how well your HDL removes cholesterol
  • Inflammatory markers: Help identify if inflammation is affecting HDL function

The Bottom Line on HDL Cholesterol

HDL cholesterol remains an important marker of cardiovascular health, earning its 'good' cholesterol designation through decades of research showing its protective effects. However, our understanding has evolved beyond the simple 'higher is better' approach. The quality and functionality of HDL particles matter as much as, if not more than, the quantity.

For most people, maintaining HDL levels between 50-80 mg/dL through healthy lifestyle choices provides optimal cardiovascular protection. Focus on regular exercise, a Mediterranean-style diet rich in healthy fats, maintaining a healthy weight, and not smoking. These interventions not only raise HDL levels but also improve HDL function and overall cardiovascular health.

Remember that HDL is just one piece of the cardiovascular puzzle. A comprehensive approach to heart health should include monitoring all lipid markers, managing blood pressure, controlling blood sugar, and addressing other risk factors. Regular testing and working with your healthcare provider can help you develop a personalized strategy for optimal cardiovascular health.

References

  1. Madsen, C. M., Varbo, A., & Nordestgaard, B. G. (2017). Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies. European Heart Journal, 38(32), 2478-2486.[Link][PubMed][DOI]
  2. Rohatgi, A., Khera, A., Berry, J. D., et al. (2014). HDL cholesterol efflux capacity and incident cardiovascular events. New England Journal of Medicine, 371(25), 2383-2393.[Link][PubMed][DOI]
  3. Kosmas, C. E., Martinez, I., Sourlas, A., et al. (2018). High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease. Drugs in Context, 7, 212525.[Link][PubMed][DOI]
  4. Bartlett, J., Predazzi, I. M., Williams, S. M., et al. (2016). Is isolated low high-density lipoprotein cholesterol a cardiovascular disease risk factor? Circulation: Cardiovascular Quality and Outcomes, 9(3), 206-212.[Link][PubMed][DOI]
  5. Ouimet, M., Barrett, T. J., & Fisher, E. A. (2019). HDL and reverse cholesterol transport: Basic mechanisms and their roles in vascular health and disease. Circulation Research, 124(10), 1505-1518.[Link][PubMed][DOI]
  6. Nordestgaard, B. G., & Varbo, A. (2014). Triglycerides and cardiovascular disease. The Lancet, 384(9943), 626-635.[Link][PubMed][DOI]

Frequently Asked Questions

How can I test my HDL cholesterol at home?

You can test your HDL cholesterol at home with SiPhox Health's Heart & Metabolic Program. This CLIA-certified program includes HDL testing along with other crucial cardiovascular biomarkers, providing lab-quality results from the comfort of your home.

What is the ideal HDL cholesterol level?

For optimal cardiovascular protection, HDL levels should be between 50-80 mg/dL for men and 50-90 mg/dL for women. Levels below 40 mg/dL for men and 50 mg/dL for women are considered low and increase cardiovascular risk.

Can HDL cholesterol ever be too high?

Yes, extremely high HDL levels (above 80-100 mg/dL) may paradoxically increase cardiovascular risk in some cases. Recent research shows a U-shaped relationship between HDL and health outcomes, suggesting that very high levels might indicate dysfunctional HDL or underlying health issues.

How quickly can I raise my HDL levels naturally?

With consistent lifestyle changes, you can see improvements in HDL levels within 6-8 weeks. Regular aerobic exercise can increase HDL by 5-10%, while dietary changes and weight loss provide additional benefits. Most experts recommend retesting after 3 months of lifestyle modifications.

Does HDL cholesterol directly remove plaque from arteries?

HDL helps prevent plaque formation by removing excess cholesterol from artery walls before it can accumulate. While HDL cannot remove established plaque, it plays a crucial role in preventing further buildup and may help stabilize existing plaques through its anti-inflammatory properties.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details